- Home
- ZS vs EW Comparison
ZS vs EW Comparison
Compare ZS & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZS
- EW
- Stock Information
- Founded
- ZS 2007
- EW 1958
- Country
- ZS United States
- EW United States
- Employees
- ZS N/A
- EW N/A
- Industry
- ZS EDP Services
- EW Industrial Specialties
- Sector
- ZS Technology
- EW Health Care
- Exchange
- ZS Nasdaq
- EW Nasdaq
- Market Cap
- ZS 45.6B
- EW 44.8B
- IPO Year
- ZS 2018
- EW 2000
- Fundamental
- Price
- ZS $302.94
- EW $73.83
- Analyst Decision
- ZS Buy
- EW Buy
- Analyst Count
- ZS 35
- EW 20
- Target Price
- ZS $293.85
- EW $80.20
- AVG Volume (30 Days)
- ZS 3.0M
- EW 3.7M
- Earning Date
- ZS 05-29-2025
- EW 07-23-2025
- Dividend Yield
- ZS N/A
- EW N/A
- EPS Growth
- ZS N/A
- EW 200.69
- EPS
- ZS N/A
- EW 7.02
- Revenue
- ZS $2,546,757,000.00
- EW $5,522,300,000.00
- Revenue This Year
- ZS $26.26
- EW $11.81
- Revenue Next Year
- ZS $20.50
- EW $9.54
- P/E Ratio
- ZS N/A
- EW $10.45
- Revenue Growth
- ZS 25.46
- EW 8.23
- 52 Week Low
- ZS $153.45
- EW $58.93
- 52 Week High
- ZS $309.19
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- ZS 75.40
- EW 39.86
- Support Level
- ZS $299.52
- EW $72.42
- Resistance Level
- ZS $308.66
- EW $76.62
- Average True Range (ATR)
- ZS 7.48
- EW 1.38
- MACD
- ZS -0.97
- EW -0.51
- Stochastic Oscillator
- ZS 80.98
- EW 23.34
About ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.